Original Source(s)
Related Content
FDA Approves Melanoma BRAF Companion Test
The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.
August 10, 2026
-
1 min
Self-Sampling Shows Test Agreement
The study authors frame the device as a potential way to simplify screening, while emphasizing that larger validation studies are still needed.
July 8, 2026
-
5 min
FDA Approves Treg Cell Therapy
A randomized clinical trial found higher chronic GVHD-free survival and lower rates of serious chronic GVHD compared with standard transplantation in adults with blood cancers.
July 1, 2026
-
2 min
